Impact of different progestins on endometrial vascularisation of postmenopausal women. A retrospective image analysis—morphometric study
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This retrospective morphometric study analyzed endometrial vascularization in postmenopausal women treated with different progestins.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectivesTo determine if the vascularisation of the endometrium is dependent on the administered progestin during sequential hormone replacement therapy.MethodsNine women received percutaneous estradiol-17 beta, 1.5 mg/day from days 1 to 24 combined with 200 mg/day micronised progesterone from days 11 to 24 of the treatment cycle. Fifteen women received percutaneous estradiol, 1.5 mg/day from days 1 to 24, combined with 10 mg/day chlormadinone acetate from days 11 to 24. Eleven women received percutaneous estradiol, 50 microg/day from days 1 to 28 combined with percutaneous norethisterone acetate, 0.3mg/day form days 14 to 28. Twelve women received intranasal estradiol, 300 microg/day from days 1 to 25 combined with 0.5 mg of promegestone from days 11 to 24. Eleven spontaneous cycling women had an endometrial biopsy during luteal phase and served as controls. Endometrial biopsies were processed routinely between days 18 and 24 and sections were immunostained using anti-CD34 antibody to identify vascular endothelial cells, which were treated with an automatic image analysis system.Resultsmean (+/-S.D.) vascular density for controls was 147+/-41.5 vessels/mm(2), with mean vessel area of 143+/-60.9 microm(2). In chlormadinone users endometrial microvascular density and mean vessel area did not differ from the control group (150.2+/-58.6 and 152.9+/-70.5). The other three progestins generated a significant increase of mean vessel density, 179.6+/-51.6 with micronised progesterone, 178.5+/-67.6 with norethisterone and 179.6+/-48.4 with promegestone. The mean vessel area was lower in the latter three groups, respectively, 108.4+/-39.0, 97.5+/-46.5 and 141.6+/-66.7 microm(2), promegestone leading to non significant difference with control.Conclusionregarding vascularisation, chlormadinone and control group gave similar patterns. Promegestone was associated with an increase of the number of vessels, as did micronised progesterone or norethisterone; the mean vascular area was the smallest in the norethisterone group.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- Antiproliferative effects of low-dose micronized progesterone via openalex
- Biopsy Pathology of the Endometrium via openalex
- Changes in vascular basement membrane in the endometrium of Norplant users via openalex
- Comparative endometrial histology in postmenopausal women with sequential hormone replacement therapy of estradiol and, either chlormadinone acetate or micronized progesterone via openalex
- Dating the Endometrial Biopsy via openalex
- Uterus and endometrium: Microvascular density in conditions of endometrial atrophy via openalex
- doi:10.1016/0010-7824(88)90087-x via openalex
- doi:10.1016/0146-664x(82)90078-8 via openalex
- doi:10.1093/oxfordjournals.humrep.a138767 via openalex
- doi:10.1093/molehr/7.1.65 via openalex
- doi:10.1093/humupd/4.5.503 via openalex
- doi:10.1016/s0140-6736(98)06196-0 via openalex
- doi:10.1093/oxfordjournals.humrep.a137767 via openalex
- doi:10.1016/s0039-128x(00)00117-3 via openalex
- doi:10.1016/0002-9378(81)90711-0 via openalex
- doi:10.1007/bf03190030 via openalex
- doi:10.1016/s0378-5122(00)00144-4 via openalex
- doi:10.1097/00042192-199502020-00007 via openalex
- doi:10.1093/oxfordjournals.humrep.a136276 via openalex
- doi:10.1007/bf00495630 via openalex
- doi:10.1093/oxfordjournals.humrep.a137138 via openalex
- doi:10.1530/rep.0.1230107 via openalex
- doi:10.1093/oxfordjournals.humrep.a138268 via openalex
- doi:10.1016/s0002-9378(97)80022-1 via openalex
- doi:10.1093/oxfordjournals.humrep.a136040 via openalex
- doi:10.1172/jci118429 via openalex
- doi:10.1093/humrep/16.6.1065 via openalex
- doi:10.1093/oxfordjournals.humrep.a019183 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-11T05:40:41.230350+00:00
- unpaywall
- last seen: 2026-08-18T06:27:49.008893+00:00
License: CC0
· commercial use OK